Behavioral health Clinical Trials in Glendale, CA
As of August 2026, 12 paid clinical trials are recruiting for Behavioral health in Glendale, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Glendale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
13 clinical trials for Behavioral health
·Clear filters·A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Study of ALTO-300 in MDD
Top Research Study Locations in Glendale
Researchers run research studies in Glendale, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Los Angeles Cancer Network | Colorectal Neoplasms, Anemia, B-Cell Non-Hodgkins Lymphoma | 9 |
| Global Research Management, Inc. | Macular Edema Secondary to Inflammation, Age-Related Macular Degeneration, Choroidal Neovascularization | 6 |
| Behavioral Research Specialists, LLC | Major Depressive Disorder (MDD), Alzheimer Disease, Depression | 6 |
| Adventist Health Glendale | Coronary Artery Disease, High-Risk Percutaneous Coronary Intervention, Hypertension | 5 |
| California Clinical Trials Medical Group | Fentanyl Overdose, Fentanyl Poisoning, Methamphetamine Abuse | 3 |
| Global Research Management | Diabetic Macular Edema, Diabetic Retinopathy, Dry Eye Disease (DED) | 3 |
| Kidney Disease Medical Group | End Stage Kidney Disease, Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases | 3 |
| Los Angeles Hematology Oncology Medical Group | Breast Cancer, Breast Neoplasms, Colorectal Neoplasms | 2 |
| Behavioral Research Specialists LLC | Depressive Disorder, Major, Generalized Anxiety Disorder | 2 |
| Glendale Adventist Medical Center | Acute Ischemic Stroke, Carcinoma, Non-Small-Cell Lung | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| OPN Healthcare, Inc. | Non-small Cell Lung Cancer | 2 |
| PAREXEL Glendale/LA EPCU | Healthy Volunteers, Hyperuricemia, Obesity | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| Los Angeles Cancer Network (LACN) | Metastatic Castration-Resistant Prostate Cancer | 1 |
| Adventist Medical Glendale | Lumbar Spinal Stenosis | 1 |
| Autobahn | Major Depressive Disorder | 1 |
| Avalon Surgery and Robotic Center | Lumbar Spinal Stenosis | 1 |
| California Clinical Trials Medical Group - Parexel | Schizophrenia | 1 |
| Children's Hospital of Los Angeles | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases | 1 |
| City of Hope at Glendale | Metastatic Pancreatic Adenocarcinoma | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Glendale Adventist | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Glendale Adventist Medical Center d/b/a Adventist Health Glendale | Acute Stroke, Ischemic Stroke, Stroke | 1 |
| Glendale, CA | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
Active & Upcoming Studies in Glendale (2026)
Recruiting trials in Glendale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (22 active studies)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
- A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation · Phase 3 · Astellas Pharma Global Development, Inc.
Eye & vision (11 active studies)
- A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO · Phase 3 · Kodiak Sciences Inc
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Cardiovascular (6 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities · Phase 3 · Weill Medical College of Cornell University
Mental health & behavior (5 active studies)
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · Cybin IRL Limited
Neurology & pain (4 active studies)
- Open-Label Extension Protocol to SNK01-AD01 Study · Phase 2 · NKGen Biotech, Inc.
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Diabetes & metabolic (3 active studies)
- Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity · Phase 1 · Regeneron Pharmaceuticals
- A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity · Phase 1 · Novo Nordisk A/S
Common conditions studied in Glendale
- Healthy Participants (6 active studies)
- Major Depressive Disorder (6 active studies)
- Breast Cancer (4 active studies)
- Major Depressive Disorder (MDD) (4 active studies)
- Colorectal Neoplasms (3 active studies)
- Coronary Artery Disease (3 active studies)
Leading research sponsors in Glendale
- AstraZeneca
- Boehringer Ingelheim
- Janssen Research & Development, LLC
- Pfizer
- Bristol-Myers Squibb
Frequently asked questions
How many paid clinical trials are currently recruiting in Glendale?
There are approximately 94 recruiting clinical trials in Glendale, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glendale pay participants?
Most recruiting trials in Glendale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glendale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glendale?
The most common conditions under active study in Glendale include Healthy Participants (6), Major Depressive Disorder (6), Breast Cancer (4), Major Depressive Disorder (MDD) (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glendale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glendale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glendale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glendale?
Recruiting research sites in Glendale include Los Angeles Cancer Network, Global Research Management, Inc., Behavioral Research Specialists, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glendale right now?
The largest active categories in Glendale are Cancer & tumors (22), Eye & vision (11), Cardiovascular (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.